Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Mental health' OR with Authors including 'Mental health' OR with Abstract including 'Mental health' OR with Keywords including 'Mental health'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Hoffer A, Osmond H, Smyth... Schizophrenia; a new approach. II. Result of a year's research J Ment Sci 1954
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
Isbell H, Miner EJ, Logan... Relationships of psychotomimetic to anti-serotonin potencies of congen... Psychopharmacologia 1959
Delay J, Pichot P, Lempér... Les effets somatiques de la Psilocybine Presse méd. 1959
Woolley DW Serotonin in mental disorders Dis.Nerv.System 1960
Vojtechovsky M, Horácková... Pokus o blokováni experimentální psychózy po LSD-25 theadrylem. Csl. Psychiat. 1960
Pollard JC, Bakker C, Uhr... Controlled sensory input: a note on the technic of drug evaluation wit... Comprehensive Psychi... 1960
Savage C, Stolaroff MJ Clarifying the Confusion Regarding LSD-25 J. Nerv. Ment. Dis. 1965
Charalampous KD, Walker K... Metabolic fate of mescaline in man Psychopharmacologia 1966
Editorial Hazards of indiscriminate use of LSD getting across New York State Journ... 1968
Raichle ME, Posner JB, Pl... Cerebral blood flow during and after hyperventilation Arch Neurol 1970
Barr HL, Langs RJ, Holt R... LSD : Personality And Experience   1972
Klerman GL Psychotropic hedonism vs pharmacological Calvinism Hastings Cent Rep 1972
Klerman GL Drugs And The Dying Patient Psychopharmalogical ... 1973
Servadio E The use of LSD in the psychoanalytic treatment of a case of anxiety hy... Zeitschrift fur Psyc... 1973
Editorial FDA Lists Approved LSD Research Projects FDA Consumer 1975
Smithells RW Environmental Teratogens Of Man 1976
O'Callaghan JP, Miller DB Quantification of reactive gliosis as an approach to neurotoxicity ass... NIDA Res Monogr 1993
Steele TD, McCann UD, Ric... 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and ... Addiction 1994
Anthony JC, Warner LA, Ke... Comparative Epidemiology of Dependence on Tobacco, Alcohol, Controlled... Experimental and Cli... 1994
Shih JC, Chen K, Gallaher... Structure and Function of Serotonin 5-HT2 Receptors NIDA Research Monogr... 1994
Takeda N, Ikeda R, Ohba K... Bufotenine reconsidered as a diagnostic indicator of psychiatric disor... Neuroreport 1995
Gerada C, Ashworth M ABC of mental health. Addiction and dependence--I: Illicit drugs [publ... BMJ 1997
Towers S [Unknown] Accid Emerg Nurs 1997
Towers S Sorted Accid Emerg Nurs 1997
Gouzoulis-Mayfrank E, Hee... Effects of the hallucinogen psilocybin on habituation and prepulse inh... Behav Pharmacol 1998
Abrahart D A Critical Review of Theories and Research Concerning Lysergic Acid Di... Masters Thesis 1998
Grof S Human nature and the nature of reality: conceptual challenges from con... J Psychoactive Drugs 1998
Pedersen W, Skrondal A Ecstasy and new patterns of drug use: A normal population study. Addiction 1999
Spruit IP Ecstasy use and policy responses in the Netherlands Journal of Drug Issu... 1999
Collins AS, Sumner SC, Bo... A physiological model for tert-amyl methyl ether and tert-amyl alcohol... Toxicol Sci 1999
Gouzoulis-Mayfrank E, The... Psychopathological, neuroendocrine and autonomic effects of 3,4-methyl... Psychopharmacology (... 1999
Lerner AG, Gelkopf M, Oyf... LSD-induced hallucinogen persisting perception disorder treatment with... Int Clin Psychopharm... 2000
Jablensky A Epidemiology of schizophrenia: the global burden of disease and disabi... Eur Arch Psychiatry ... 2000
Hafner H Epidemiology of schizophrenia. A thriving discipline at the turn of th... Eur Arch Psychiatry ... 2000
Schreckenberger M, Gouzou... "Ecstasy"-induced changes of cerebral glucose metabolism and their cor... Eur J Nucl Med 2000
Weinbroum AA, Rudick V, P... The role of dextromethorphan in pain control Can J Anaesth 2000
Cami J, Farre M, et al Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'): p... J Clin Psychopharmac... 2000
Liechti ME, Gamma A, Voll... Gender Differences in the Subjective Effects of MDMA Psychopharmacology 2001
Degenhardt L, Hall W The association between psychosis and problematical drug use among Aus... Psychol Med 2001
Pacifici R, Zuccaro P, Lo... Acute effects of 3,4-methylenedioxymethamphetamine alone and in combin... J Pharmacol Exp Ther 2001
McCann UD, Ricaurte GA Caveat Emptor: Editors Beware Neuropsychopharmacol... 2001
Braff, DL, Geyer, MA and ... Human studies of prepulse inhibition of startle: normal subjects, pati... Psychopharmacology 2001
Lerner AG, Skladman I, Ko... LSD-induced Hallucinogen Persisting Perception Disorder treated with c... Isr J Psychiatry Rel... 2001
Gerra G, Zaimovic A, Ampo... Experimentally induced aggressive behavior in subjects with 3,4- methy... Journal of Substance... 2001
Johns LC, van Os J The continuity of psychotic experiences in the general population Clin Psychol Rev 2001
Klitzman RL, Greenberg JD... MDMA ('ecstasy') use, and its association with high risk behaviors, me... Drug Alcohol Depend 2002
Szabo Z, McCann UD, Wilso... Comparison of (+)-(11)C-McN5652 and (11)C-DASB as Serotonin Transporte... J Nucl Med 2002
Gouzoulis-Mayfrank E, The... Effects of the hallucinogen psilocybin on covert orienting of visual a... Neuropsychobiology 2002
Wachtel SR, ElSohly MA, R... Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol ... Psychopharmacology (... 2002
Gouzoulis-Mayfrank E, The... Effects of the hallucinogen psilocybin on covert orienting of visual a... Neuropsychobiology 2002
Solomon PR, Adams F, Silv... Ginkgo for memory enhancement: a randomized controlled trial JAMA 2002
Eisen SA, Chantarujikapon... Does marijuana use have residual adverse effects on self-reported heal... Addiction 2002
Bellis MA, Hughes K, Lowe... Healthy nightclubs and recreational substance use. From a harm minimis... Addict Behav 2002
Riba J, Rodri­guez-Fornel... Effects of ayahuasca on sensory and sensorimotor gating in humans as m... Psychopharmacology (... 2002
Jorm LR, Thackway SV, Chu... Watching the Games: public health surveillance for the Sydney 2000 Oly... J Epidemiol Communit... 2003
Halpern JH, Sholar MB, Gl... Diminished interleukin-6 response to proinflammatory challenge in men ... J Clin Endocrinol Me... 2003
Page WF Long-term health effects of exposure to sarin and other anticholineste... Mil Med 2003
Kim MK, Nightingale C, Ni... Influence of sex on the pharmacokinetic interaction of fleroxacin and ... Clin Pharmacokinet 2003
Reijneveld SA, Crone MR, ... The effect of a severe disaster on the mental health of adolescents: a... Lancet 2003
Verheyden SL, Henry JA, C... Acute, sub-acute and long-term subjective consequences of 'ecstasy' (M... Hum Psychopharmacol 2003
Lamers CT, Ramaekers JG, ... Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor ... J Psychopharmacol 2003
Verheyden SL, Maidment R,... Quitting ecstasy: an investigation of why people stop taking the drug ... J Psychopharmacol 2003
Wyatt JK, Cajochen C,Ritz... Low-Dose Repeated Caffeine Administration for Circadian-Phase–Dependen... SLEEP 2004
Roth BL, Lopez E, Beische... Screening the receptorome to discover the molecular targets for plant-... Pharmacol Ther 2004
Halpern JH Hallucinogens and dissociative agents naturally growing in the United ... Pharmacol Ther 2004
Pierre JM, Shnayder I, Wi... Intranasal quetiapine abuse Am J Psychiatry 2004
Kukanich B, Papich MG Plasma profile and pharmacokinetics of dextromethorphan after intraven... J Vet Pharmacol Ther 2004
Drewe M, Drewe J, Riecher... Cannabis and risk of psychosis Swiss Med Wkly 2004
Isaac M, Isaac M, Hollowa... Is cannabis an anti-antipsychotic? The experience in psychiatric inten... Hum Psychopharmacol 2005
Gebhardt DO Off-label administration of drugs to healthy military personnel. Dubio... J Med Ethics 2005
Peters RJ, Kelder SH, Mes... Beliefs and social norms about cigarettes or marijuana sticks laced wi... Subst Use Misuse 2005
Halpern JH, Sherwood AR, ... Psychological and Cognitive Effects of Long-Term Peyote Use Among Nati... Biological Psychiatr... 2005
Halpern JH, Sewell RA Hallucinogenic botanicals of America: a growing need for focused drug ... Life Sci 2005
Halpern JH, Sewell RA Hallucinogenic Botanicals of America: A growing need for focused drug ... Life Sci 2005
Wittmann M, Carter O, Has... Effects of psilocybin on time perception and temporal control of behav... J Psychopharmacol 2006
Padosch SA, Lachenmeier D... Absinthism: a fictitious 19th century syndrome with present impact Subst Abuse Treat Pr... 2006
Zarate CA, Singh JB, Carl... A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... Arch Gen Psychiatry 2006
Kleber HD Commentary on: Psilocybin can occasion mystical-type experiences havin... Psychopharmacology (... 2006
Rasmussen N Making the first anti-depressant: amphetamine in American medicine, 19... J Hist Med Allied Sc... 2006
Tanner-Smith EE Pharmacological content of tablets sold as 'ecstasy': results from an ... Drug Alcohol Depend 2006
Furey ML, Drevets WC Antidepressant efficacy of the antimuscarinic drug scopolamine: a rand... Arch Gen Psychiatry 2006
Robertson JR, Raab GM, Br... Addressing the efficacy of dihydrocodeine versus methadone as an alter... Addiction 2006
Moore TH, Zammit S, Lingf... Cannabis use and risk of psychotic or affective mental health outcomes... Lancet 2007
Vainiotalo S, Riihimäki V... Toxicokinetics of methyl tert-butyl ether (MTBE) and tert-amyl methyl ... J Occup Environ Hyg 2007
Deakin JF, Lees J, McKie ... Glutamate and the neural basis of the subjective effects of ketamine: ... Arch Gen Psychiatry 2008
Cifelli CJ, Green JB, Wan... Kinetic analysis shows that vitamin A disposal rate in humans is posit... J Nutr 2008
Burri A, Heinrichs M, Sch... The acute effects of intranasal oxytocin administration on endocrine a... Psychoneuroendocrino... 2008
Muetzelfeldt L, Kamboj SK... Journey through the K-hole: phenomenological aspects of ketamine use Drug Alcohol Depend 2008
McDonough PC, Holler JM, ... The detection and quantitative analysis of the psychoactive component ... J Anal Toxicol 2008
Bossong MG, van Berckel B... Delta9-Tetrahydrocannabinol Induces Dopamine Release in the Human Stri... Neuropsychopharmacol... 2008
Tupper KW Entheogenic healing: The spiritual effects and therapeutic potential o... Book: The Healing Po... 2009
Khan MA, Akella S Cannabis-induced bipolar disorder with psychotic features: a case repo... Psychiatry (Edgmont) 2009
Comer SD, Sullivan MA, Vo... Abuse liability of oxycodone as a function of pain and drug use histor... Drug Alcohol Depend 2010
Karila L, Reynaud M GHB and synthetic cathinones: clinical effects and potential consequen... Drug Test Anal 2010
Kelly BC Legally tripping: a qualitative profile of Salvia divinorum use among ... J Psychoactive Drugs 2011
Wu LT, Woody GE, Yang C, ... Recent national trends in Salvia divinorum use and substance-use disor... Subst Abuse Rehab 2011
Parrott AC, Gibbs A, Scho... MDMA and methamphetamine: some paradoxical negative and positive mood ... Psychopharmacology (... 2011
Parrott AC Residual neurocognitive features of ecstasy use: a re-interpretation o... Addiction 2011
Bar-Or D, Salottolo KM, O... A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Eva... Eur Urol 2011

Page 1 of 2   /   144 Entries Returned
2 next